http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2472535-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc414cfc9619d2c5cbaee5bc9b94c64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-06
filingDate 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f8e0bfacdcb3fa36e4fb5f79476259c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e70568d5651821e667f5258e399f1f39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_553e3c1d89293aee12f6af609eeef1ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df69c6047cdd01b7590af79ad8ab20e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b355c6cf15e7b6feedc60aeabac9d1e
publicationDate 2013-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2472535-C1
titleOfInvention Method of treating essential arterial hypertension in adolescents with obstructive sleep apnoea/hypnoea syndrome
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely paediatrics, cardiology, somnology, and may be used for treating adolescents with essential arterial hypertension with obstructive sleep apnoea/hypnoea syndrome. For this purpose, nasal non-invasive lung ventilation by nocturnal nasal continuous positive airway pressure (nCPAP-therapy) and light therapy with a therapeutic health-improving lamp with underlying standard therapeutic regimens. The nCPAP-therapy involves 10 monthly procedures for three months with a session length of 8 hours. The light therapy are performed once a day during a first hour after wakening up, a length of procedure is 30 minutes; the therapeutic course is 10 days for a first month of therapy. n EFFECT: method provides normalising the blood pressure level ensured by correcting obstructive respiratory sleeping disorders and normalising the circadian rhythm system. n 1 ex
priorityDate 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2379035-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-66282-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1602391-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2334529-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443955
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID110799
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID110799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408215224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451646703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1547484

Total number of triples: 30.